Overview:
Healthcare analytics or healthcare analytical testing is a process of data collection from varied sources and their analysis for indicating trends for delivering improved healthcare. Tools such as predictive analytics, prescriptive analytics and descriptive analytics are the major analytical techniques used in healthcare analytical testing. Digital recording of clinical data is helpful in creating and maintaining paperless repository and eventually in improving process, efficiency and accuracy of clinical outcomes and thus the healthcare system.
Resource scarcity, regulatory issues on healthcare providers and insurance providers,and need for disease monitoring etc. are some of the critical issues that are claimed to be efficiently addressed by healthcare analytical testing market. Apart from operational advantages, healthcare analytical testing also efficiently improvises revenue management cycle and healthcare record consolidation. Widespread use of healthcare analytical testing could also aid in national preventive care, healthcare policy framing and efficient health financing across both developed and developing countries. Risk of data breach, cultural barriers and risk of skilled personnel may challenge the market growth to a certain extent.
The global healthcare analytical testing market is segmented on the following bases:
1. Testing Type
a. Bioanalytical Testing
b. Physical Characterization
c. Method Validation
d. Raw Material Testing
e. Batch Release Testing
f. Stability Testing
g. Microbial Testing
h. Environmental Monitoring
2. Sample Type
a. Raw Materials
b. Finished Products
c. In-Process Sample
d. Environmental Sample
3. End-Users
a. Medical Device Manufacturers
b. Pharmaceuticals Manufacturers
c. Contract Research Organizations
d. Governments
4. Geography
a. North America
i. US
ii. Canada
b. Europe
i. UK
ii. Germany
iii. Rest of Europe
c. Asia-Pacific
i. Japan
ii. China
iii. Rest of APAC
d. Latin America
e. Middle East and Africa
Key players identified for healthcare analytical testing market include but are not limited to:
Eurofins Scientific SE, Charles River Laboratories International Inc., Exova Group PLC, Envigo, Medistri SA, WUXI Pharmatech (Cayman) Inc., SGS, Pace Analytical Services Inc., PPD Inc., and severalothers
This report offers: